C
ADNT icon

Cerebellum’s Adient ADNT Stock Holding History

Cerebellum’s Portfolio ADNT Stock Details ADNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-15,745
Closed -$237K – 436
2018
Q4 		$237K Buy
+15,745
New +$407K 0.16% 247

Other funds holding ADNT

DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BHG
Blue Harbour Group Greenwich, Connecticut $353M AUM 8.9% 1-Year Est. Return
LAM
Lyrical Asset Management New York $6.56B AUM 20.06% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
LBA
Letko, Brosseau & Associates Montreal, Quebec, Canada $6.2B AUM 38.92% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
LCM
Lakewood Capital Management New York $1.58B AUM 0.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Cerebellum's ADNT Position: Q1 2019 in Review

Cerebellum sold out of Adient (ADNT) in Q1 2019, closing a stake of 15,745 shares — an estimated $237K sold.

Cerebellum first reported a position in ADNT in Q4 2018 and held it in 1 quarter. The position peaked at $237K in Q4 2018. 352 funds tracked by Wall St. Rank hold ADNT as of Q1 2019.

  • Cerebellum reported no remaining Adient position as of Q1 2019 after selling out during the quarter.
  • Cerebellum sold 15,745 Adient shares in Q1 2019, an estimated $237K.
  • Cerebellum first reported a position in Adient in Q4 2018 and held it in 1 quarter.
  • Cerebellum's Adient position peaked at $237K in Q4 2018.
  • 352 funds tracked by Wall St. Rank held Adient as of Q1 2019.

Based on Cerebellum's 13F filing for Q1 2019, filed 21 May 2019.